Liquidia Corporation, (LQDA) is a biopharmaceutical company. It develops, manufactures & commercializes various products for unmet patient needs in the United States. It comes under Healthcare sector in Biotechnology Industry & trades as “LQDA” ticker at Nasdaq.
As discussed in last article, it extends rally in impulse I from June-2025 low. It should extend into $38.16 – $40.90 area to finish the wave ((5)) as I before correction start. We like to buy the pullback in 3, 7 or 11 swings at extreme area, when reach.
LQDA – Elliott Wave Latest Weekly View:
In weekly, it broke the previous ATH from October-2018 in last rally & confirms bullish bias. It favors rally in I of (III) against June-2025 low. From August-2021 low, it placed I of (I) at $7.78 high, II at $4.06 low, III at $16.99 high, IV at $8.26 low & V at $19.41 high in May-2025. It corrected lower in (II) in 3 swings, which ended at $11.85 low in June-2025 low. Above (II) low, it placed ((1)) of I at $29.94 high, ((2)) at $21.15 low, ((3)) at $36.41 high, ((4)) at $29.30 low & favors rally in ((5)).
LQDA – Elliott Wave View From 8.25.2025:
Within ((1)), it ended (1) at $20.33 high, (2) at $16.82 low, (3) at $28.82 high (4) at $26.06 low & (5) at $29.94 high. Within ((3)), it placed (1) at $25.12 high, (2) at $21.94 low, (3) at $35.54 high, (4) at $32.11 low & (5) at $36.41 high. Currently, it favors rally in (1) of ((5)) & expect minor high before correcting in (2). As long as it stays above $29.30 low of 1.05.2026, it should extend higher in 5 swings to finish ((5)). The ((5)) expects to extend into $38.16 – $40.90 area to finish I impulse before correcting next. It already reached the minimum area, so if it breaks below $29.30 low, it can be II as alternate view. We like to buy the pullback in 3, 7 or 11 swings in II against June-2025 low. If it managed to erase the momentum divergence, then it can be nesting in I.
Source: https://elliottwave-forecast.com/stock-market/lqda-buy-breakout-wait-pullback/